| 发明名称 |
BILAYER TABLET FORMULATIONS |
| 摘要 |
The present invention relates to bilayer tablet formulations comprising metformin extended release (XR) or reduced mass metformin XR formulation as the first layer, an SGLT2 inhibitor formulation as the second layer, and optionally a film coating. The present invention provides methods of preparing the bilayer tablet formulations and methods of treating diseases or disorders associated with SGLT2 activity employing the bilayer tablet formulations. |
| 申请公布号 |
US2012282336(A1) |
申请公布日期 |
2012.11.08 |
| 申请号 |
US201013509210 |
申请日期 |
2010.11.12 |
| 申请人 |
ABEBE ADMASSU;MARTIN KYLE;PATEL JATIN M.;DESAI DIVYAKANT;TIMMINS PETER;ASTRAZENECA UK LIMITED;BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
ABEBE ADMASSU;MARTIN KYLE;PATEL JATIN M.;DESAI DIVYAKANT;TIMMINS PETER |
| 分类号 |
A61K9/24;A61K31/155;A61K31/7034;A61K38/26;A61K38/28;A61P3/04;A61P3/06;A61P3/10;A61P9/10;A61P9/12;A61P13/12;A61P17/02;A61P25/00;A61P27/02;A61P27/12 |
主分类号 |
A61K9/24 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
